Your browser doesn't support javascript.
loading
Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis.
Peng, Kuan; Blais, Joseph E; Pratt, Nicole L; Guo, Jeff Jianfei; Hillen, Jodie B; Stanford, Tyman; Ward, Michael; Lai, Edward Chia-Cheng; Shin, Ju-Young; Tong, Xinning; Fan, Min; Cheng, Franco W T; Wu, Jing; Yeung, Winnie W Y; Lau, Chak-Sing; Leung, Wai Keung; Wong, Ian C K; Li, Xue.
Afiliação
  • Peng K; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Blais JE; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
  • Pratt NL; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
  • Guo JJ; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Hillen JB; Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
  • Stanford T; James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA.
  • Ward M; Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
  • Lai EC; Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
  • Shin JY; Pharmacy Education, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
  • Tong X; Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
  • Fan M; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Cheng FWT; Department of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Seoul, South Korea.
  • Wu J; Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea.
  • Yeung WWY; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Lau CS; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
  • Leung WK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China.
  • Wong ICK; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
  • Li X; Division of Rheumatology and Clinical Immunology, Queen Mary Hospital, Pok Fu Lam, Hong Kong SAR, China.
BioDrugs ; 37(3): 409-420, 2023 May.
Article em En | MEDLINE | ID: mdl-36952213
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares Idioma: En Ano de publicação: 2023 Tipo de documento: Article